The technology developed by De Motu Cordis utilises the pulmonary pathway to deliver life saving medications via the lungs. Due to the surface area of the lungs being approximately fifty times larger than the area of a patient’s skin, medications rapidly absorb into the blood stream providing a fast and effective treatment.
Emergency solutions for the immediate treatment of life threatening conditions
DMC Inhaler for Anaphylaxis
The first generation of inhaler has been developed to provide emergency treatment of anaphylaxis by delivering adrenaline through inhalation.
With a rapid onset of action, the inhaler can be used without hesitation to provide relief of anaphylaxis before the onset of severe symptoms.
The inhaler aims to improve upon the current standard of care by being: